UZE Array posts 33 percent Q4 2025 EPS miss shares dip 115 percent on soft investor sentiment CIF MFS High Inc shares no quarterly earnings metrics as financial and operational data remain undisclosed this period ATII Archimedes 2 leadership prioritizes highgrowth tech merger targets to deliver upside for investors XPeng Inc XPEV Stock Is It an Attractive Investment Q4 2025 Profit Exceeds Views LB Pharmaceuticals LBRX Business Model Review LB Pharmaceuticals Beats EPS Estimates With Narrower Loss